Pages that link to "Q72150100"
Jump to navigation
Jump to search
The following pages link to Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States (Q72150100):
Displaying 50 items.
- Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication (Q21144733) (← links)
- Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland (Q23920406) (← links)
- Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status (Q24241852) (← links)
- The periodic health examination: 2. 1984 update. Canadian Task Force on the Periodic Health Examination (Q24548741) (← links)
- Randomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future (Q24600011) (← links)
- Comparison of the accelerated and classic vaccination schedules against Hepatitis B: three-week Hepatitis B vaccination schedule provides immediate and protective immunity (Q24799985) (← links)
- Viral hepatitis and the surgeon (Q27481282) (← links)
- The Gordon Wilson Lecture. The ABC's of viral hepatitis (Q27486030) (← links)
- An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis (Q27860909) (← links)
- Hepatitis B and the Need for a Booster Dose (Q28239937) (← links)
- Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans (Q28487831) (← links)
- Death and epidemiology in Bangladesh (Q28768093) (← links)
- A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen (Q30152118) (← links)
- Acceptance of hepatitis B vaccine by medical and surgical residents (Q30461403) (← links)
- Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies (Q33559657) (← links)
- Hepatitis among hospital employees. (Q33580423) (← links)
- Immunogenicity of hepatitis B virus vaccine (Heptavax-B)--response of healthy adults (Q33581088) (← links)
- Hepatitis B virus markers in prostitutes in Singapore (Q33582712) (← links)
- Update on diagnosis, management, and prevention of hepatitis B virus infection (Q33588921) (← links)
- Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals (Q33699077) (← links)
- Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity (Q33701455) (← links)
- A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients (Q33725100) (← links)
- Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. (Q33759392) (← links)
- Secretion of the hepatitis B virus surface antigen from mouse cells using an extra-chromosomal eucaryotic vector (Q33933483) (← links)
- Sexually transmitted hepatitis: a review (Q33933564) (← links)
- Hepatitis A seroprevalence in homosexual and heterosexual men. (Q33935001) (← links)
- Hepatitis B virus antigens made in microbial cells immunise against viral infection (Q33939409) (← links)
- Oral immunization with hepatitis B surface antigen expressed in transgenic plants (Q33944696) (← links)
- Hepatitis B virus: where do we stand and what is the next step for eradication? (Q33958764) (← links)
- Hepatitis B vaccine: prospects for duration of immunity (Q34050389) (← links)
- Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1 (Q34077801) (← links)
- Alternative dosage schedules with HPV virus-like particle vaccines (Q34102466) (← links)
- Cost-effectiveness of a potential vaccine for Coccidioides immitis (Q34105429) (← links)
- Correlates of incident infections for HIV, syphilis, and hepatitis B virus in a cohort of men who have sex with men in Beijing (Q34213856) (← links)
- Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen (Q34225571) (← links)
- Adverse events after hepatitis B vaccination (Q34275183) (← links)
- IgG1 is pathogenic in Leishmania mexicana infection (Q34337676) (← links)
- Strategies for hepatitis B immunisation (Q34395230) (← links)
- Surveillance and control of infectious diseases: progress toward the 1990 objectives. (Q34506051) (← links)
- The Timing of Hepatitis B Virus (HBV) Immunization Relative to Human Immunodeficiency Virus (HIV) Diagnosis and the Risk of HBV Infection Following HIV Diagnosis (Q34514263) (← links)
- In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements (Q34616508) (← links)
- Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays (Q34623193) (← links)
- Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis: an update (Q34685875) (← links)
- Protein therapeutics: a summary and pharmacological classification (Q34728463) (← links)
- Prevalence of hepatitis A, B and C in the Flemish population (Q34742570) (← links)
- Hepatitis B and C Virus Sexual Transmission Among Homosexual Men (Q34744802) (← links)
- Hepatitis B virus infection in medical and health care personnel (Q34747370) (← links)
- Priorities for immunisation against hepatitis B. (Q34750261) (← links)
- Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemic (Q34891397) (← links)
- Physicians infrequently adhere to hepatitis vaccination guidelines for chronic liver disease (Q34907938) (← links)